Here, we uncover that CysLT1 antagonists, but not CysLT2 antagonists, produce significant anti-cancer effect in primary and metastatic UM cell lines through the inhibition of cell survival and cell proliferation.96 hours of drug treatment in short-term cell viability and long-term cell proliferation assays revealed interesting results. Here, CYSLTR1 is linked to cancer.